Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

169
(from Reference Citation Analysis)

Article PDFs (2)

Cited by ≥ 1 (31)

Searched Name

R. Govindan

Year Published

Show more Refine

Article Statistics

Refine

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Journal Articles

Number	Citation Analysis
126	Wenzelburger R, Raethjen J, Pohle S, Govindan R, Morsnowski A, Deuschl G. Parkinsonian action tremor in a grip-lift task: interference with object manipulation and lacking levodopa response. AKTUELLE NEUROLOGIE 2005. [DOI: 10.1055/s-2005-919186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
127	Hanna N, Bonomi P, Lynch T, Ansari R, Govindan R, Janne P, Lilenbaum R. O-106 A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC). Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80240-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
128	Bradley J, Graham M, Swann S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, Gore E, Choy H. P-603 Phase I results of RTOG L-0117; a phase i/II dose intensificationstudy using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81096-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
129	Natale R, Bodkin D, Govindan R, Sleckman B, Rizvi N, Capo A, Germonpré P, Dimery I, Webster A, Ranson M. O-103 A comparison of the antitumour efficacy of ZD6474 and gefitinib(Iressa™) in patients with NSCLC: Results of a randomized, double-blind Phase II study. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80237-5] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
130	Gralla R, Edelman M, Detterbeck F, Jahan T, Loesch D, Limentani S, Govindan R, Obasaju C, Bloss L, Socinski M. P-617 Evaluating the impact of neoadjuvant chemotherapy and surgeryon quality of life (QL) in patients with early stage NSCLC: A prospective analysis of the GINEST project. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)81110-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
131	Fanucchi M, Fossella F, Fidias P, Natale R, Belt R, Govindan R, Raez L, Schiller J, Kashala O, Kelly K. O-084 Phase 2 study of bortezomib±docetaxel in advanced non-smallcell lung cancer (NSCLC). Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80217-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
132	Socinski M, Detterbeck F, Gralla R, Edelman M, Jahan T, Loesch D, Limentani S, Govindan R, Bloss L, Obasaju C. O-115 Induction chemotherapy with gemcitabine-containing regimensin stage I–II non-small cell lung cancer (NSCLC): Initial results of the GINEST* Project. Lung Cancer 2005. [DOI: 10.1016/s0169-5002(05)80249-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
133	Govindan R, Crowley J, Schwartzberg L, Kennedy P, Ekstrand BC, Sandler A, Jaunakais D, Ghalie R. Phase II trial of bexarotene capsules in patients with non-small-cell lung cancer (NSCLC) who have failed at least 2 prior systemic therapies for Stage IIIB/IV disease. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7116] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
134	Pillot GA, Hennenfent K, Read W, Marsh S, McLeod HL, Gao F, Govindan R. A phase II and pharmacogenomic study of Irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
135	Fanucchi MP, Fossella F, Fidias P, Natale RB, Belt RJ, Carbone DP, Govindan R, Raez L, Robert F, Schiller J. Bortezomib ± docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): A phase 2 study. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7034] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
136	Bradley JD, Graham M, Suzanne S, Byhardt R, Govindan R, Fowler J, Purdy J, Michalski J, Gore E, Choy H. Phase I results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with Inoperable NSCLC. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7063] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
137	Lilenbaum R, Bonomi P, Ansari R, Lynch T, Govindan R, Janne P, Hanna N. A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC): Final results. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7036] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
138	Gralla RJ, Edelman MJ, Detterbeck FC, Jahan TM, Loesch DM, Limentani SA, Govindan R, Obasaju CK, Bloss LP, Socinski MA. The impact of neoadjuvant chemotherapy and surgery on quality of life (QL) in patients with early stage NSCLC: A prospective analysis of the GINEST project. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8092] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
139	Reiling RB, Natale R, Wade J, Herbst R, Hensing T, Belani CP, Kelly K, Ochs J, Govindan R, Wozniak A, Krebs A. Efficacy and safety of gefitinib in chemo-naive patients with non-small cell lung cancer (NSCLC) in an expanded access program (EAP). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
140	Moore AM, Estes D, Govindan R, Vinson J, Calley C, Yu M, Einhorn L, Hanna N. A phase II trial of gefitinib in patients with chemosensitive and chemorefractory relapsed neuroendocrine cancers. A Hoosier Oncology Group Trial. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
141	Wang XF, Govindan R, Herndon JE, Barrier RC, Watson D, Florence R, Vokes EE, Green MR. A phase II study of carboplatin, etoposide and exisulind in patients with extensive stage small cell lung cancer: CALGB 30104. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7161] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
142	Viswanathan AK, Goodgame B, Lim WT, Gao F, Hennenfent K, Subramanian J, Miller CR, Battafarano R, Govindan R. Outcomes of resected stage 1 non-small cell lung cancer (NSCLC) in patients (Pts) aged 70 years and older. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.8027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
143	Detterbeck FC, Socinski MA, Gralla RJ, Edelman MJ, Jahan TM, Loesch DM, Limentani SA, Govindan R, Bloss LP, Obasaju CK. Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early stage non-small cell lung cancer (NSCLC): Initial results of the GINEST • project. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
144	Morgensztern D, Lim WT, Subramanian J, Viswanathan A, Govindan R. Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7298] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
145	Read WL, Govindan R, James J, Picus J. Phase I study of bexarotene and rosiglitazone in patients with refractory cancers. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.3165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
146	Goodgame B, Viswanathan A, Pillot G, Gao F, Morgensztern D, Bradley J, Guthrie T, Battafarano R, Govindan R. Outcomes in 708 resected stage I non-small cell lung cancer (NSCLC) subjects and a prognostic index for relapse. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
147	Church RD, Yu J, Fleshman JW, Shannon WD, Govindan R, McLeod HL. RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer. Br J Cancer 2004;91:1015-8. [PMID: 15328521 PMCID: PMC2747709 DOI: 10.1038/sj.bjc.6602119] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open Abstract Cyclooxygenases (particularily Cox-2) are involved in carcinogenesis and metastatic cancer progression. The expression profiles of the cyclooxygenases and the roles they play in established tumours of similar stage remains unclear. We report that Cox-1 and Cox-2 expression is highly variable in Dukes' C tumours, and changes in Cox-1 expression may be of importance. Collapse Key Words Collapse MESH Headings Base Sequence Colorectal Neoplasms/enzymology Colorectal Neoplasms/genetics Colorectal Neoplasms/mortality Colorectal Neoplasms/pathology Cyclooxygenase 1 Cyclooxygenase 2 DNA Primers Humans Intestinal Mucosa/enzymology Isoenzymes/genetics Membrane Proteins Neoplasm Staging Polymerase Chain Reaction/methods Prostaglandin-Endoperoxide Synthases/genetics RNA, Neoplasm/genetics Reference Values Ribotyping/methods Survival Analysis Time Factors Transcription, Genetic/genetics Collapse Grants P30 CA091842 NCI NIH HHS U01 GM063340 NIGMS NIH HHS GM 63340 NIGMS NIH HHS P30 CA 091842 NCI NIH HHS Collapse
148	Lynch TJ, Lilenbaum R, Bonomi P, Ansari R, Govindan R, Janne PA, Hanna N. A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7084] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
149	Read WL, Toles L, Romvari E, Adkins D, McLeod H, Govindan R. Phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC): Updated results of an ongoing study. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse
150	Zinner R, Govindan R, Wozniak AJ, Wade JL, Belani CP, Thienelt CD, Hensing TA, Reiling RB, Natale RB, Wiznitzer I. Compassionate use experience with gefitinib in poor performance (PS) patients with advanced non-small-cell lung cancer (NSCLC) treated in an expanded access program (EAP). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse